Examine the clinical traits of chronic kidney disease (CKD) for prompt diagnosis and treatment initiation Assess the real-world implications of recent clinical trial findings on SGLT-2 inhibitors for disease progression in a diverse patient population with CKD and/or heart failure (HF) Incorporate the ADA-KDIGO consensus recommendations along with other guidelines such as ESC-HF, ADA, and AHA in designing treatment protocols for patients suffering from CKD and/or HF, irrespective of their diabetes status. Develop strategies for using SGLT-2 inhibitors in patients with and without diabetes to improve cardiorenal outcomes Apply approaches to coordinated interdisciplinary care for cardiorenal metabolic patients throughout the system from a center of excellence
- Provider:Global Learning Collaborative
- Activity Link: https://medtelligence.net/
- Start Date: 2024-01-02 06:00:00
- End Date: 2024-01-02 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all